BriaCell Therapeutics Corp Warrant 2026-15.01.31 On BriaCell Therap
No trades
−48.76 USD
−26.49 M USD
0.00 USD
6.13 M
About BriaCell Therapeutics Corp
Sector
Industry
CEO
William V. Williams
Website
Headquarters
West Vancouver
Founded
2006
Identifiers
3
ISIN CA1079301257
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.